Koide joined Southern Research’s infectious disease program in 2007. He has 18 years of experience in research and program leadership, and he specializes in animal studies to evaluate novel vaccines and therapeutics for emerging infectious diseases including dengue, Zika, and yellow fever. In his previous experience, he worked at Nabi Pharmaceuticals, where he was involved in the research and development of a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA). He previously worked Memorial Sloan-Kettering Cancer Center, where he worked on studies related to newly developed cancer vaccines and also was involved in more than 10 phase 1 and phase 2 clinical trials. He is currently directing multiple dengue and Zika vaccine pre-clinical and clinical programs for commercial and government clients. His most recent research interests focus on the animal model development for Zika virus infection. Koide received his master’s degree in immunology and microbiology at the New York Medical College.
May 16, 2022 | Southern Research
April 27, 2022 | Southern Research
January 18, 2022 | Southern Research